We are pleased to see the court is taking steps to move the Biomet hip litigation forward as expeditiously as possible.
New York, New York (PRWEB) February 27, 2013
Biomet hip implant lawsuits involving the metal-on-metal Biomet M2a Magnum Hip Replacement System continue to move forward in U.S. District Court, Northern District of Indiana, Bernstein Liebhard LLP reports. According to a Case Management Order dated February 15th, the Court will now allow Biomet hip implant lawsuits to be filed directly in the Northern District of Indiana, in order to eliminate delays associated with the transfer of cases from other federal district courts. Among other things, the Order also establishes procedures for discovery in the Biomet litigation. (In re: Biomet M2a Magnum Hip Implant Products Liability Litigation – MDL No. 2391)
“We continue to hear from Biomet M2a Magnum Hip recipients who have allegedly experienced serious complications following the failure of their device. We are pleased to see the court is taking steps to move the Biomet hip litigation forward as expeditiously as possible,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices. The Firm is actively filing lawsuits on behalf of Biomet M2a Magnum hip recipients, and continues to offer free and confidential legal reviews to individuals allegedly injured by the metal-on-metal hip implant.
Metal-on-Metal Hip Implant Lawsuits
The Biomet M2a Magnum Hip is a metal-on-metal hip implant system, in which the ball and cup consist of a chromium/cobalt alloy. Court documents indicate that at least 141 Biomet hip lawsuits have been filed in the federal litigation so far. Plaintiffs allege the all-metal design of the M2a Magnum can generate high levels of metal ions, leading to metallosis in the surrounding tissue and early failure of the device.
Metal-on-metal hip replacements, like the Biomet M2a Magnum hip, are currently the subject of a U.S. Food & Drug Administration (FDA) safety review. The Biomet M2a Magnum and other all-metal hips were approved by the agency through its 510(k) process, which does not require human clinical testing. On January 17th, the FDA proposed an order requiring manufacturers of metal-on-metal total hip replacement systems to submit premarket approval (PMA) applications, which would make them ineligible for 510(k) clearance. The agency has also recommended that doctors consider metal ion testing for all-metal hip replacement patients who are experiencing symptoms of a failing implant, including pain, swelling, loosening of the implant, or change in the ability to walk.*
In addition to Biomet, a number of other metal hip implant manufacturers have been named in lawsuits alleging the devices are prone to premature failure, and can expose patients to dangerous amounts of metal ions. The lawyers at Bernstein Liebhard LLP are actively filing claims in the multidistrict litigation established in the U.S. District Court, Northern District of Ohio, for actions involving the DePuy ASR hip implant (MDL No. 2197). The firm is also involved in the federal litigation underway in the Northern District of Texas concerning the metal-on-metal DePuy Pinnacle hip device (MDL No. 2244). Bernstein Liebhard LLP partner Jeffrey S. Grand is serving on the Plaintiffs’ Steering Committee in the Pinnacle hip litigation.
Free case evaluations are also being offered to patients impacted by the July 2012 Stryker Rejuvenate recall, and the June 2012 Smith & Nephew metal liner recall. In addition, Bernstein Liebhard LLP continues to investigate cases concerning the Wright Profemur and Conserve metal hip implants.
Victims of metallosis, hip implant failure, and other serious complications allegedly caused by metal-on-metal hip replacements may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. For more information on filing a Biomet hip implant lawsuit, as well as additional information regarding complications associated with metal-on-metal hip implants, please visit Bernstein Liebhard’s website. For additional information, please contact one of our attorneys today by calling 1-877-779-1414.
About Bernstein Liebhard
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP